Covidien's (COV) pharmaceuticals business, which it's spinning off under the name Mallinckrodt, will apply to list its shares on the NYSE and will trade with the ticker symbol MNK. Covidien expects to complete the process in the middle of the year. Mallinckrodt generated sales of $2B in 2012. (PR)
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Investor's Business Daily (Jan 22, 2015)
at MarketWatch.com (Jan 17, 2015)
at Nasdaq.com (Jan 13, 2015)
at CNBC.com (Jan 12, 2015)
at Investor's Business Daily (Jan 8, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs